Novozymes A/S Series B | |
Stock Exchange | Other OTC |
EPS |
$1.66 |
Market Cap |
$13.54 B |
Shares Outstanding |
243.26 M |
Public Float |
- |
Novozymes A/S ADR | |
Stock Exchange | Other OTC |
EPS |
$1.66 |
Market Cap |
$10.92 B |
Shares Outstanding |
237.26 M |
Public Float |
- |
Novozymes A/S Series B | |
Stock Exchange | Copenhagen Stock Exchange |
EPS |
DKK10.71 |
Market Cap |
DKK89.37 B |
Shares Outstanding |
237.26 M |
Public Float |
209.59 M |
Novozymes A/S Series B | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR1.45 |
Market Cap |
EUR13.79 B |
Shares Outstanding |
243.26 M |
Public Float |
- |
Address |
Krogshoejvej 36 Copenhagen CR 2880 Denmark |
Employees | - |
Website | http://www.novozymes.com |
Updated | 07/08/2019 |
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. |